Clinical trial
Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation: An Open-label Randomized Controlled Trial (PROACTIVE)
NCT04467086 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation: An Open-label Randomized Controlled Trial (PROACTIVE)
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 8, 2021
- Completion date
- November 30, 2022
- Enrollment
- 72 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
covid, critical illness, mechanical ventilation, sedation